BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Prognosis
31 results:

  • 1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comparative analyses of the prognosis, tumor immune microenvironment, and drug treatment response between left-sided and right-sided colon cancer by integrating scRNA-seq and bulk RNA-seq data.
    Cao L; Zhang S; Yao D; Ba Y; Weng Q; Yang J; Zhang H; Ren Y
    Aging (Albany NY); 2023 Jul; 15(14):7098-7123. PubMed ID: 37480572
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Long noncoding RNA UFC1 acts as an oncogene via stimulating EZH2-induced inhibition of apc expression in renal cell carcinoma.
    Wang J; Liu G
    Cell Mol Biol (Noisy-le-grand); 2023 Apr; 69(4):152-156. PubMed ID: 37329532
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Hypoxia-inducible factor pathway genes predict survival in metastatic clear cell renal cell carcinoma.
    Tamukong PK; Kuhlmann P; You S; Su S; Wang Y; Yoon S; Gong J; Figlin RA; Janes JL; Freedland SJ; Halabi S; Small EJ; Rini BI; Kim HL
    Urol Oncol; 2022 Nov; 40(11):495.e1-495.e10. PubMed ID: 35973929
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Multiple primary malignances managed with surgical excision: a case report with next generation sequencing analysis.
    Romano C; Di Gregorio S; Pennisi MS; Tirrò E; Broggi G; Caltabiano R; Manzella L; Ruggieri M; Vigneri P; Di Cataldo A
    Mol Biol Rep; 2022 Sep; 49(9):9059-9064. PubMed ID: 35715605
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Small cell variant of chromophobe renal cell carcinoma: Clinicopathologic and molecular-genetic analysis of 10 cases.
    Rogala J; Kojima F; Alaghehbandan R; Ptakova N; Bravc A; Bulimbasic S; Perez Montiel D; Slisarenko M; Ali L; Kuthi L; Pivovarcikova K; Michalova K; Bartovic B; Bartos Vesela A; Dolejsova O; Michal M; Hes O
    Bosn J Basic Med Sci; 2022 Jul; 22(4):531-539. PubMed ID: 35276058
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prognostic Factors and a Nomogram Predicting Overall Survival and Cancer-Specific Survival for Patients with Collecting Duct Renal Cell Carcinoma.
    Xiao R; Liu C; He W; Ma L
    Biomed Res Int; 2021; 2021():6736008. PubMed ID: 34805402
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Preclinical Evaluation of Sodium Selenite in Mice: Toxicological and Tumor Regression Studies after Striatum Implantation of Human Glioblastoma Stem Cells.
    Larrouquère L; Berthier S; Chovelon B; Garrel C; Vacchina V; Paucot H; Boutonnat J; Faure P; Hazane-Puch F
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638987
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Characteristics and prognosis of Colorectal Cancer after Liver or kidney Transplantation.
    Kim M; Kim CW; Hwang S; Kim YH; Lee JL; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JC; Han DJ; Lee SG
    World J Surg; 2021 Oct; 45(10):3206-3213. PubMed ID: 34235562
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A genomic instability-derived risk index predicts clinical outcome and immunotherapy response for clear cell renal cell carcinoma.
    Wu S; Li X
    Bioengineered; 2021 Dec; 12(1):1642-1662. PubMed ID: 33955826
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Genetic profile and immunohistochemical study of clear cell renal carcinoma: Pathological-anatomical correlation and prognosis.
    Diez-Calzadilla NA; Noguera Salvá R; Soriano Sarrió P; Martínez-Jabaloyas JM
    Cancer Treat Res Commun; 2021; 27():100374. PubMed ID: 33932757
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Immunohistochemical Expression of Emerin in Renal Cell Carcinomas: Does It Contribute to Histopathological Features and WHO/ISUP Grading in Predicting prognosis?
    Argon A; Dal G; Salman T
    J Environ Pathol Toxicol Oncol; 2021; 40(2):89-98. PubMed ID: 33822520
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Preoperative anaemia and thrombocytosis predict adverse prognosis in non-metastatic renal cell carcinoma with tumour thrombus.
    Xiao R; Xu C; He W; Liu L; Zhang H; Liu C; Ma L
    BMC Urol; 2021 Feb; 21(1):31. PubMed ID: 33639914
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Complement factor H-deficient mice develop spontaneous hepatic tumors.
    Laskowski J; Renner B; Pickering MC; Serkova NJ; Smith-Jones PM; Clambey ET; Nemenoff RA; Thurman JM
    J Clin Invest; 2020 Aug; 130(8):4039-4054. PubMed ID: 32369457
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. c-Src Promotes Tumorigenesis and Tumor Progression by Activating PFKFB3.
    Ma H; Zhang J; Zhou L; Wen S; Tang HY; Jiang B; Zhang F; Suleman M; Sun D; Chen A; Zhao W; Lin F; Tsau MT; Shih LM; Xie C; Li X; Lin D; Hung LM; Cheng ML; Li Q
    Cell Rep; 2020 Mar; 30(12):4235-4249.e6. PubMed ID: 32209481
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Construction and analysis of circular RNA molecular regulatory networks in clear cell renal cell carcinoma.
    Ma C; Qin J; Zhang J; Wang X; Wu D; Li X
    Mol Med Rep; 2020 Jan; 21(1):141-150. PubMed ID: 31746384
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. HMGA1-mediated miR-671-5p targets apc to promote metastasis of clear cell renal cell carcinoma through Wnt signaling.
    Chi XG; Meng XX; Ding DL; Xuan XH; Chen YZ; Cai Q; Wang A
    Neoplasma; 2020 Jan; 67(1):46-53. PubMed ID: 31686521
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The age-adjusted Charlson comorbidity index as a predictor of overall survival of surgically treated non-metastatic clear cell renal cell carcinoma.
    Kang HW; Kim SM; Kim WT; Yun SJ; Lee SC; Kim WJ; Hwang EC; Kang SH; Hong SH; Chung J; Kwon TG; Kim HH; Kwak C; Byun SS; Kim YJ;
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):187-196. PubMed ID: 31606760
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. prognosis of renal cell carcinoma with bone metastases: Experience from a large cancer centre.
    Ruatta F; Derosa L; Escudier B; Colomba E; Guida A; Baciarello G; Loriot Y; Fizazi K; Albiges L
    Eur J Cancer; 2019 Jan; 107():79-85. PubMed ID: 30551078
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Wilms Tumor Associated With the 9q22.3 Microdeletion Syndrome: 2 New Case Reports and a Review of The Literature.
    Cayrol J; Nightingale M; Challis J; Campbell M; Sullivan M; Heloury Y
    J Pediatr Hematol Oncol; 2019 Nov; 41(8):e517-e520. PubMed ID: 30371535
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.